A strong debut from SoftBank’s Arm Holdings last week raised hopes of a rebound in the IPO market, but the lukewarm reception to Neumora Therapeutics has tempered some optimism.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
